These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26228388)

  • 21. Successful comeback of the single-dose live oral cholera vaccine CVD 103-HgR.
    Herzog C
    Travel Med Infect Dis; 2016; 14(4):373-7. PubMed ID: 27425792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF; Dietrich G; Favre D
    Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.
    Lagos R; Fasano A; Wasserman SS; Prado V; San Martin O; Abrego P; Losonsky GA; Alegria S; Levine MM
    J Infect Dis; 1999 Nov; 180(5):1709-12. PubMed ID: 10515838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
    Wasserman SS; Losonsky GA; Noriega F; Tacket CO; Castañeda E; Levine MM
    Vaccine; 1994 Aug; 12(11):1000-3. PubMed ID: 7975839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live oral vaccines against cholera: an update.
    Levine MM; Kaper JB
    Vaccine; 1993; 11(2):207-12. PubMed ID: 8438619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
    Mayo-Smith LM; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Calderwood SB; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.
    Lagos R; Avendaño A; Prado V; Horwitz I; Wasserman S; Losonsky G; Cryz S; Kaper JB; Levine MM
    Infect Immun; 1995 Feb; 63(2):707-9. PubMed ID: 7822046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial.
    McCarty JM; Lock MD; Bennett S; Hunt KM; Simon JK; Gurwith M
    Vaccine; 2019 Mar; 37(11):1389-1397. PubMed ID: 30772070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.
    Taylor DN; Sanchez JL; Castro JM; Lebron C; Parrado CM; Johnson DE; Tacket CO; Losonsky GA; Wasserman SS; Levine MM; Cryz SJ
    Infect Immun; 1999 Apr; 67(4):2030-4. PubMed ID: 10085055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults.
    Migasena S; Pitisuttitham P; Prayurahong B; Suntharasamai P; Supanaranond W; Desakorn V; Vongsthongsri U; Tall B; Ketley J; Losonsky G
    Infect Immun; 1989 Nov; 57(11):3261-4. PubMed ID: 2807523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
    Cryz SJ; Que JU; Levine MM; Wiedermann G; Kollaritsch H
    Infect Immun; 1995 Apr; 63(4):1336-9. PubMed ID: 7890391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaxchora: A Single-Dose Oral Cholera Vaccine.
    Cabrera A; Lepage JE; Sullivan KM; Seed SM
    Ann Pharmacother; 2017 Jul; 51(7):584-589. PubMed ID: 28622736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.
    Chen WH; Garza J; Choquette M; Hawkins J; Hoeper A; Bernstein DI; Cohen MB
    Clin Vaccine Immunol; 2015 Jan; 22(1):129-35. PubMed ID: 25410205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels.
    Gotuzzo E; Butron B; Seas C; Penny M; Ruiz R; Losonsky G; Lanata CF; Wasserman SS; Salazar E; Kaper JB
    Infect Immun; 1993 Sep; 61(9):3994-7. PubMed ID: 8359923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
    Losonsky GA; Tacket CO; Wasserman SS; Kaper JB; Levine MM
    Infect Immun; 1993 Feb; 61(2):729-33. PubMed ID: 8423098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial Commentary: Resurrecting a Live Oral Cholera Vaccine.
    Harris JB
    Clin Infect Dis; 2016 Jun; 62(11):1336-7. PubMed ID: 27001802
    [No Abstract]   [Full Text] [Related]  

  • 37. CVD 103-HgR vaccine for travelers.
    Wong KK; Mahon BE; Reingold A
    Travel Med Infect Dis; 2016; 14(6):632-633. PubMed ID: 27693492
    [No Abstract]   [Full Text] [Related]  

  • 38. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.
    Fakoya B; Sit B; Waldor MK
    J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with registered mucosal vaccines.
    Dietrich G; Griot-Wenk M; Metcalfe IC; Lang AB; Viret JF
    Vaccine; 2003 Jan; 21(7-8):678-83. PubMed ID: 12531339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults.
    Muhsen K; Sow SO; Tapia MD; Haidara FC; Reymann M; Asato V; Chen WH; Pasetti MF; Levine MM
    Sci Rep; 2020 Oct; 10(1):16871. PubMed ID: 33037244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.